Marked increase of insulin gene transcription by suppression of the Rho/Rho-kinase pathway

Yumiko Nakamura1, Hideaki Kaneto, Takeshi Miyatsuka

  • 1Department of Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.

Insights

Rho/Rho-kinase is activated in pancreatic beta-cells during diabetes, suppressing insulin production. Inhibiting this pathway boosts insulin gene transcription, offering a potential therapeutic strategy for type 2 diabetes.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Cell Biology

Background:

  • Type 2 diabetes is characterized by pancreatic beta-cell dysfunction and insulin resistance.
  • The role of Rho/Rho-kinase signaling in beta-cell function was previously unknown.
  • Rho/Rho-kinase is implicated in insulin signaling, insulin resistance, and glucose homeostasis.

Purpose of the Study:

  • To investigate the role of the Rho/Rho-kinase pathway in pancreatic beta-cell function.
  • To determine if Rho/Rho-kinase influences insulin biosynthesis and secretion.

Main Methods:

  • Immunostaining to detect RhoA expression in beta-cells.
  • Evaluation of Rho-kinase inhibitors (Y-27632, fasudil) on insulin biosynthesis.
  • Northern blot analysis to measure insulin mRNA levels.
  • Luciferase reporter gene assay to assess insulin promoter activity.

Main Results:

  • RhoA expression was higher in beta-cells of diabetic mice.
  • Rho-kinase inhibitors significantly increased insulin mRNA levels in beta-cell lines.
  • Inhibition of Rho-kinase enhanced insulin promoter activity, correlating with increased insulin mRNA.

Conclusions:

  • Rho/Rho-kinase is activated in beta-cells under diabetic conditions, contributing to suppressed insulin expression.
  • Suppression of the Rho/Rho-kinase pathway enhances insulin gene transcription.
  • Targeting the Rho/Rho-kinase pathway may represent a novel therapeutic approach to augment insulin production in diabetes.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...